Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia.
about
β-thalassemia intermedia: a clinical perspectiveEffect of acetylsalicylic acid on thalassemia with pulmonary arterial hypertensionSpleen R2 and R2* in iron-overloaded patients with sickle cell disease and thalassemia major.Benefits of chronic blood transfusion in hemoglobin E/β thalassemia with pulmonary arterial hypertensionPulmonary hypertension in well-transfused thalassemia major patientsWhen to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia.Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network reportNitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disordersPost splenectomy related pulmonary hypertension.Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertensionVascular complications after splenectomy for hematologic disorders.β-Thalassemia Intermedia: A Bird's-Eye View.Platelets in pulmonary hypertension: a causative role or a simple association?Pulmonary hypertension associated with thalassemia syndromes.Review of the Association between Splenectomy and Chronic Thromboembolic Pulmonary Hypertension.Morbidities in non-transfusion-dependent thalassemia.Hematological disorders and pulmonary hypertension.Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published works.Prevalence of Pulmonary Hypertension in Patients with Thalassemia Intermedia in 2009: a single center's experience.Morbidity and mortality of adult patients with congenital dyserythropoietic anemia type I.Pulmonary hypertension in non-transfusion-dependent thalassemia: Correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron.Pulmonary hypertension in hemolytic anemiasThe 6-min walk test: an independent correlate of elevated tricuspid regurgitant jet velocity in children and young adult sickle cell patients.N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.Frequency of pulmonary hypertension in asymptomatic β-thalassemia major patients and the role of physiological parameters in evaluation.Management of pulmonary arterial hypertension associated to thalassemia: when pulmonary endarterectomy is the best therapeutical option? A case report.Soluble fms-Like Tyrosine Kinase 1 as a Link Between Angiogenesis and Endothelial Dysfunction in Pediatric Patients With β-Thalassemia Intermedia.Prevalence and risk factors for pulmonary hypertension in patients with hemoglobin E/β-thalassemia disease.
P2860
Q26828512-113F4979-A4C3-48F3-A5E5-7D90B12C87F4Q33419337-727A4335-CF31-4307-8FCC-A45177C651D8Q34004503-AC849CBC-C41A-4484-AF02-A09FAAC1F905Q34094137-4E66CD81-350D-4617-8671-29A12A98F32FQ34979478-451513FA-F117-4A00-AC8B-04D9909BA9FBQ34999542-3E3E423C-EFF4-4C16-8925-3D0ECB5E54D3Q35346284-DFE560B7-47B4-4626-9673-2E001C5041A6Q35590733-80103737-EC03-45EE-A807-195C33F3C440Q36653460-81B13E04-C363-4A10-85C4-950D361517DEQ37144856-F698D38D-B980-46A7-A09F-9C3983994F63Q37373000-C3300B82-1793-46B0-92B0-72A5E4A8AF1EQ37718392-D678D6E3-0283-49AB-B808-EE49EE5C308DQ38051350-AC6EB897-CFF4-4121-9FEC-1733631CF3E1Q38786355-D5801C5C-9EB2-492E-95AC-5EE6EFC011FBQ38801779-7918E978-BAFB-426E-9D7C-22858D648937Q38836177-98C314B3-328A-42F9-8E62-64EACE193641Q39077582-AE4EF4FA-A39A-448E-821F-DEE1EE1CC6AFQ39408329-2157DF27-9BB4-4256-A6CF-98DC8F98A088Q40519846-CFEE040D-1175-4F41-A93B-5D6D8321E55DQ40744253-FC0BA695-EFEA-42F2-AC85-2B2B4859AB94Q41745150-7D0A7741-BF31-4EDA-BD73-9A169F303492Q42415504-37263C7E-E2FD-4A5D-92A3-42456D657FA1Q42454675-9437E707-C41E-4766-A66F-C71EED40A5EEQ43180474-12B6A454-93D1-469F-816A-A65D842609ECQ43934420-2C57A017-5C17-478B-8770-92301D2454E5Q45800063-F2806561-50CF-43A7-95A0-2584F753419CQ46154480-EB2AF4B6-DCF9-4169-82CB-E1594E75DAEDQ46223563-E65D9147-F26F-4040-9409-C95EE25F0C36Q53078962-018E61D6-351A-492A-8B33-801D10837B5D
P2860
Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Splenectomy: a strong risk fac ...... in patients with thalassaemia.
@ast
Splenectomy: a strong risk fac ...... in patients with thalassaemia.
@en
type
label
Splenectomy: a strong risk fac ...... in patients with thalassaemia.
@ast
Splenectomy: a strong risk fac ...... in patients with thalassaemia.
@en
prefLabel
Splenectomy: a strong risk fac ...... in patients with thalassaemia.
@ast
Splenectomy: a strong risk fac ...... in patients with thalassaemia.
@en
P2093
P2860
P356
P1433
P1476
Splenectomy: a strong risk fac ...... in patients with thalassaemia.
@en
P2093
A Phrommintikul
A Sukonthasarn
R Kanjanavanit
W Nawarawong
P2860
P304
P356
10.1136/HRT.2005.079970
P407
P577
2006-04-18T00:00:00Z